Abstract:Purpose: Congenital aniridia is a severe malformation of almost all eye segments. In addition, endocrinological, metabolic, and central nervous systems diseases may be present. In order to develop better treatment options for this rare disease, an aniridia center must be established. The purpose of this work is to summarize ophthalmic findings of aniridia subjects examined at the Department of Ophthalmology, Saarland University Medical Center in Homburg. Methods: Our retrospective single-center study included patients who underwent a comprehensive ophthalmic examination through the head of the KiOLoN ("Kinderophthalmologie", Orthoptics, Low Vision and Neuroophthalmology) Unit of the department between June 2003 and January 2022. Data at the first examination time point have been included. Results: Of 286 subjects, 556 eyes of (20.1 ± 20.1 years; 45.5% males) were included. There was nystagmus in 518 (93.7%) eyes, and strabismus in 327 (58.8%) eyes. There were 436 (78.4%) eyes with age-appropriate axial length, 104 (18.7%) eyes with microphthalmos, and 13 (2.3%) eyes with buphthalmos. There was iris malformation with atypical coloboma in 34 eyes (6.1%), more than 6 clock hours of iris remnants in 61 eyes (10.9%), less than 6 clock hours of iris remnants in 96 eyes (17.2%), and complete aniridia in 320 (57.5%) eyes. The patients were graded according to the following aniridia-associated keratopathy (AAK) stages: Stage 0 (96 eyes [17.2%], no keratopathy), Stage 1 (178 eyes [32.0%]), Stage 2 (107 eyes [19.2%]), Stage 3 (67 eyes [12.0%]), Stage 4 (62 eyes [11.1%]), Stage 5 (45 eyes [8.0%]). There was secondary glaucoma in 307 (55.5%), macular hypoplasia in 395 (71.4%), and congenital optic nerve head pathology in 223 (40.3%) eyes. The iris malformation type was significantly positively correlated with AAK stage, lens properties, presence of glaucoma, congenital macular, and optic nerve head properties (p < 0.001 for all), while complete aniridia showed the most complications. Conclusions: At the Homburg Aniridia Center, the most common ophthalmic signs in congenital aniridia were AAK, iris malformation, cataract, and macular hypoplasia. The iris malformation type may indicate future expression of AAK, cataract, and glaucoma development and it is correlated with a congenital optic nerve head and macular pathology. Our registry will support further detailed longitudinal analysis of ophthalmic and systemic diseases of aniridia subjects during long-term follow-up.

Ocular surface inflammation in congenital eye diseases

Update in gene therapies or innovative therapies in aniridia associated keratopathy

Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies

Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches

Clinical and molecular aspects of congenital aniridia - A review of current concepts

New horizons in aniridia management: Clinical insights and therapeutic advances

The limbal stem cell niche in development, insights from mouse models and children with aniridia

Clinical and diagnostic imaging profile of three anterior segment dysgenesis disorders presenting with infantile corneal opacities

Corneal opacities in children

Epigenetic regulation of the anterior segment diseases and potential therapeutics.

Congenital Aniridia and Ocular motility

A Cross-sectional Analysis of 556 Eyes Entering the Homburg Aniridia Centre

Primary congenital glaucoma: An iridotrabeculodysgenesis?

Syndromic congenital glaucoma clinical features and therapeutic results

Non infectious ocular surface inflammation: Paediatric GVHD

Basic mechanisms and clinical implications of ocular surface inflammation

Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study

Potential Involvements of Anterior Segment Dysgenesis-Associated Genes in Primary Congenital Glaucoma

Ophthalmic Complications of Atopic Dermatitis in Children

The inflammasome pathway: A key player in ocular surface and anterior segment diseases

Ophthalmic involvement in PHACES syndrome: prevalence, spectrum of anomalies, and outcomes